Welcome to The PhRMA Foundation

Over the past 48 years, the PhRMA Foundation has helped thousands of scientists advance their careers and has inspired new generations to enter biopharmaceutical research. The early-career support provided by the PhRMA Foundation has been a catalyst for our scientists to become leaders in their organizations and fields. Our programs help build a larger pool of highly-trained researchers to meet the growing needs of academic institutions, the government and the research-intensive pharmaceutical industry.

The PhRMA Foundation funds scientists at critical points in their research careers to support and reward innovation in disciplines essential to the development of safe and effective medicines. The PhRMA Foundation offers competitive pre and post doctoral fellowships, sabbatical fellowships, and research starter grants to advance science in pharmacology, toxicology, informatics, pharmaceutics, and health outcomes. The Foundation also offers a Comparative Effectiveness Research Center of Excellence Award.

PhRMA Foundation award recipients will continue to play an instrumental role in substantial achievements in medicine for the benefit of public health and ultimately the patient.

Learn more about past grant and award recipients. Download a PDF version of the Foundation's Annual Report. [
2011 Annual Report]

Juan Lertora Receives PhRMA Foundation Award in Excellence

Washington, D.C. (March 6, 2013) — Juan J. L. Lertora, MD, PhD, is the 2013 recipient of the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Award in Excellence in Clinical Pharmacology. The award program, now in its 15th year, honors former Foundation grant recipients for outstanding career achievements.

Darrell Abernethy, MD, PhD, Chair of the Foundation’s Clinical Pharmacology Advisory Committee, will present the award to Dr. Lertora on March 6, 2013, at the American Society for Clinical Pharmacology and Therapeutics (ASCPT) Annual Meeting in Indianapolis.

Dr. Lertora is Director of the Clinical Pharmacology Program at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland, and an Adjunct Professor of Medicine at Duke University. He also serves on the faculty for the NIH–Duke Master’s Program in Clinical Research. Before coming to the NIH, Dr. Lertora was an Assistant Professor of Medicine and Pharmacology at Northwestern University’s Clinical Pharmacology Center, where he was awarded a three-year PhRMA Foundation (at that time, Pharmaceutical Manufacturers Association [PMA] Foundation) Faculty Development Award in Clinical Pharmacology. After transitioning to the positions of Associate Professor of Medicine and Pharmacology and Section Head of Clinical Pharmacology at Tulane University School of Medicine in New Orleans, he received a PMA Foundation Clinical Pharmacology Unit Award. Dr. Lertora established the first joint academic section of clinical pharmacology between the Departments of Medicine and Pharmacology at Tulane in 1981 and later rose to the rank of Professor of Medicine and Pharmacology. In his 25 years at the university, he served as a physician, clinical investigator, teacher, trainer, and mentor, advising medical and graduate students, resident physicians, and postdoctoral fellows.

Dr. Lertora graduated with honors from the Faculty of Medicine, National University of the Northeast in Argentina, and earned his doctorate from Tulane University’s Department of Pharmacology. While at Tulane, Dr. Lertora received a Merck Sharp & Dohme International Fellowship in Clinical Pharmacology. He completed his training in Internal Medicine at the University of Connecticut and pursued a fellowship in Clinical Pharmacology at the University of Iowa.

Since 2006, Dr. Lertora has managed the NIH Principles of Clinical Pharmacology course for NIH trainees, staff scientists, and national and international distance learning partners. He also oversees special training programs in clinical pharmacology for postdoctoral fellows, residents, and medical students.

Throughout his career, Dr. Lertora has achieved recognition for his work in education. In December 2008, he received the NIH Clinical Center Director’s Award for Teaching and Training. In addition to acknowledging his management of the Principles of Clinical Pharmacology course, the award also lauded his efforts to establish elective rotations at the Food and Drug Administration (FDA), introducing NIH clinical research trainees to the regulatory sciences. In July 2010, Dr. Lertora was recognized by the NIH Director with the Ruth L. Kirschstein Mentoring Award.

Dr. Lertora was Program Director of the NIH–funded General Clinical Research Center of Tulane–Louisiana State University (LSU)–Charity Hospital from 1998 to 2005, and Principal Investigator of the Tulane–LSU Adult AIDS Clinical Trials Unit from 1996 to 2005. He is an editorial board member for Clinical Pharmacology and Therapeutics—ASCPT’s scholarly journal—and served on the organization’s Board of Directors as Vice President and At-Large Director. He is a Fellow of the American College of Physicians and American College of Clinical Pharmacology. As a member of the Adult AIDS Clinical Trial Group, Dr. Lertora studied drug effects and interactions in HIV-positive individuals.

About the Awards in Excellence
Many scientists who receive PhRMA Foundation grants early in their careers have achieved extraordinary success in academic, government, and industry positions. These awards support the Foundation’s goal to meet the needs of the pharmaceutical industry and young scientists. Award in Excellence recipients exemplify the very best in clinical pharmacology and pharmacology/toxicology.

Applications for the PhRMA Foundation Fall Programs will be accepted beginning July 1, 2013.
Do not begin an application before July 1, 2013 as our application system is being updated and changes to the system will be made.

The new 2014 brochures for Pharmacology/Toxicology, Informatics and Pharmaceutics are now available.
The 2014 Comparative Effectiveness Research, Clinical Pharmacology, Health Outcomes, and Translational Medicine brochures will be posted to this site as they become available.


Translational Medicine and Therapeutics [see program overview]

Click here to view application components:

Center for Adherence Improvement Young Investigator Grant Program  Application deadline: September 15, 2013 (http://www.phrmafoundation.org/adherence)

  • Pre-Doctoral Fellowship Award
  • Post-Doctoral Fellowship Award
  • Research Starter Grant

Pharmacology/Toxicology [view brochure] (Deadline: September 1, 2013)

Informatics [view brochure] (Deadline: September 1, 2013)

Clinical Pharmacology (view information) (Deadline: February 1, 2014)

  • Paul Calabresi Medical Student Research Fellowship (view details)
  • Faculty Development Award in Clinical Pharmacology (view details)

Pharmaceutics [view brochure] (Deadline: September 1, 2013)

Health Outcomes [view brochure] (Deadline: February 1, 2014)

Center of Excellence for Comparative Effectiveness Research [view flier] (Deadline September 15, 2013)
(view details)

Like us on facebook and follow PhRMA Foundation news and events

 

BENEFACTORS


The PHRMA Foundation owes its success to the pharmaceutical companies that have provided their generous support over the past 45 years.Use the arrows to scroll benefactors and click their logo to learn more about them.

View all benefactors.

 

Left direction
Right direction
logo

(C) 2013 PhRMA Foundation - 950 F Street, N.W. Suite 300 Washington, DC 20004